A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada
Journal of Analytical Toxicology · 2024
DOI: 10.1093/jat/bkae034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Zachary Currie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Section, Centre of Forensic Sciences, 25 Morton Shulman Ave, Toronto, ON M3M 0B1, Canada. Hauptthemen laut MEDLINE: Cocaine, Substance Abuse Detection, Driving Under the Influence. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Drug-impaired driving is an increasing public safety concern across Canada, particularly due to the demonstrated increase in use of recreational drugs such as cocaine. Cocaine is a central nervous system stimulant drug; however, it can impair an individual’s driving ability in both the stimulant and crash phases. Despite the scientific consensus regarding cocaine’s potential for driving impairment, there is relatively little information available regarding blood concentrations and associated observations of impairment in suspected impaired drivers. Retrospective data analysis was performed to evaluate suspected impaired driving cases in which cocaine and/or benzoylecgonine were detected alone, or in combination with other drugs, in blood and urine samples submitted to the Toxicology Section of the Centre of Forensic Sciences with incident dates between 2021 and 2022. Cocaine and/or benzoylecgonine were detected in 46% (blood) and 66% (urine) of the total impaired driving samples submitted. In 41 cases where cocaine and/or benzoylecgonine were the only drug finding in blood, concentrations of cocaine and benzoylecgonine ranged from 0.0073 to 0.26 mg/L (mean 0.096 mg/L) and 0.13 to 5.3 mg/L (mean 2.1 mg/L), respectively. Driving observations reported by the arresting officer in cases where cocaine and/or benzoylecgonine were the only drug finding in blood and urine included the driver being involved in a collision, the vehicle leaving the roadway, erratic driving and the driver being asleep at the wheel; observations of drug impairment reported by the drug recognition expert at the time of driver evaluation included abnormal speech patterns, poor balance/incoordination, abnormal body movements and the individual falling asleep. The results provide concentrations of cocaine and benzoylecgonine observed in suspected impaired drivers, insight into observations that may be associated with prior cocaine use and additional information to inform on the effects of cocaine on driving.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Toxicology Section, Centre of Forensic Sciences, 25 Morton Shulman Ave, Toronto, ON M3M 0B1, Canada.
- Department of Forensic Science, Laurentian University, 935 Ramsey Lake Road, Sudbury, ON P3E 2C6, Canada.
ORCID-Profile: Zachary Currie
Zitieren
APA
Currie, Z., Lamparter, C., Gosselin, S., & Watterson, J. (2024). A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae034
Vancouver
Currie Z, Lamparter C, Gosselin S, Watterson J. A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada. Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae034
BibTeX
@article{Currie2024,
author = {Currie, Zachary and Lamparter, Christina and Gosselin, Sophie and Watterson, James},
title = {A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada},
journal = {Journal of Analytical Toxicology},
year = {2024},
doi = {10.1093/jat/bkae034}
}
EUVIMED